AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22106979
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 4 mg / Pioglitazone 30 mg
Trial: 22106979
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 4 mg / Pioglitazone 15 mg
Trial: 22106979
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 8 mg / Pioglitazone 0 mg
Trial: 22106979
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 0 mg / Pioglitazone 30 mg
Trial: 22106979
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 0 mg / Pioglitazone 0 mg
Trial: 17545701
Drug: Single-dose nevirapine
RxNorm normalized name: Nevirapine
DrugBank: Nevirapine (DB00238)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose nevirapine (sd-NVP) prophylaxis
Trial: 11212969
Drug: Cortisol 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol 80 mg/day + L-arginine 21 g/day
Trial: 11212969
Drug: Cortisol 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol 80 mg/day + Placebo
Trial: 7753427
Drug: Nicardipine (80-120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine (80-120 mg daily)
Trial: 7753427
Drug: Nifedipine (40-60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (40-60 mg daily)
Trial: 3058537
Drug: Dothiepin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dothiepin (75 mg orally at night)
Trial: 18854803
Drug: Lactobacillus rhamnosus
RxNorm normalized name: Lactobacillus Rhamnosus
DrugBank: Lacticaseibacillus rhamnosus (DB19282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14 (Dicoflor Elle, Dicofarm, Roma, Italy) administered orally, two tablets daily for 15 days
Trial: 18854803
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy followed by Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14
Trial: 10937511
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (30 microg/ml zinc)
Trial: 10937511
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (80 microg/ml zinc)
Trial: 8765253
Drug: Subcutaneous closed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous closed drainage system
Trial: 8765253
Drug: No subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No subcutaneous closed drainage system
Trial: 8765253
Drug: Subcutaneous closed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous closed drainage system with prophylactic antibiotics
Trial: 8765253
Drug: No subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No subcutaneous closed drainage system without prophylactic antibiotics
Trial: 1576070
Drug: Terbutaline inhaled
RxNorm normalized name: terbutaline Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline inhaled via Turbohaler (TBH) at varying inspiratory flows (34 to 88 l min‐1)
Trial: 1576070
Drug: Terbutaline inhaled
RxNorm normalized name: terbutaline Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline inhaled via Turbohaler (TBH) with prior exhalation through the device
Trial: 1576070
Drug: Terbutaline inhaled
RxNorm normalized name: terbutaline Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline inhaled via Turbohaler (TBH) at approximately 34 l min‐1
Trial: 27339736
Drug: BAY 81-8973
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BAY 81-8973 prophylaxis (twice-weekly vs. three times-weekly dosing)
Trial: 25048508
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of tramadol 100 mg in 500 mL 0.9%NaCl one hour before the procedure
Trial: 25048508
Drug: 500 mL
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mL 0.9%NaCl (control group)
Trial: 25048508
Drug: Postoperative analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative analgesia (diclofenac 75 mg i.m.) when required
Trial: 22158143
Drug: Vibration treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vibration treatment at 25 Hz, 35 Hz, and 45 Hz with low amplitude (1 mm) and high amplitude (3.1 mm)
Trial: 22158143
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of a soft pad during vibration treatment
Trial: 22158143
Drug: Vibration treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vibration treatment (various frequencies and amplitudes)
Trial: 18041883
Drug: Posaconazole 200
RxNorm normalized name: posaconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posaconazole 200 mg oral suspension 3 times/day for a maximum of 16 weeks
Trial: 11028251
Drug: Heparin i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin i.v. bolus
Trial: 11028251
Drug: Pilot study
RxNorm normalized name: Picot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilot study of bolus dosing
Trial: 29376858
Drug: Exercise Training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise Training (ET), 90 minutes of aerobic and strength training, 72 treatment sessions over 6 months
Trial: 29376858
Drug: Cognitive Treatment
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Treatment (CT), 90 minutes of cognitive stimuli
Trial: 26162946
Drug: High-dose therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose therapy with rosuvastatin (5 mg for 4 weeks, then 10 mg for 8 weeks)
Trial: 26162946
Drug: Low-dose therapy
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose therapy with rosuvastatin (2.5 mg for 12 weeks)
Trial: 18617126
Drug: Transdermal fentanyl
RxNorm normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal fentanyl patch (TFP) - Duragesic 50 microg/h, applied approximately 10 hours before induction of general anesthesia
Trial: 15975304
Drug: Breviscapine intravenously
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breviscapine intravenously dripped for 2 treatment courses
Trial: 16021880
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of didanosine plus stavudine plus nevirapine with hydroxyurea
Trial: 16021880
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of didanosine plus stavudine plus nevirapine without hydroxyurea
Trial: 20427778
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (800 IU daily)
Trial: 12242596
Drug: Fluoxetine as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine as the experimental drug
Trial: 12242596
Drug: Fluoxetine as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine as the control drug
Trial: 9819017
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg (with HCTZ 12.5 mg increased to 25 mg)
Trial: 9819017
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS 30 mg (increased to 60 mg and 90 mg)
Trial: 2547410
Drug: Fluconazole (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (50 mg daily for 21-28 days)
Trial: 2547410
Drug: Control (before
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (before fluconazole therapy)
Trial: 21695251
Drug: Replication-defective Ad5
RxNorm normalized name: covid-19, viral vector, non-replicating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Replication-defective Ad5 gag/pol/nef vaccine
Trial: 19229545
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation the day before the operation (n = 41)
Trial: 12547889
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro (0.1 units/kg body wt)
Trial: 12547889
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin (0.1 units/kg body wt)
Trial: 4025217
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of Ba-wei-wan
Trial: 24843973
Drug: Combination electroacupuncture
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination electroacupuncture anesthesia (group B)
Trial: 22640930
Drug: 2.5 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 g/d n-3 PUFAs
Trial: 22640930
Drug: 1.25 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 g/d n-3 PUFAs
Trial: 18235121
Drug: Both doses
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both doses (400 mg/d and 600 mg/d)
Trial: 15783259
Drug: Proven effective
RxNorm normalized name: Propoven
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Proven effective therapy
Trial: 12020263
Drug: Budipine 20
RxNorm normalized name: budipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budipine 20 mg, 3 times daily
Trial: 7883776
Drug: Mesna administration
RxNorm normalized name: Mesna
DrugBank: Coenzyme M (DB09110)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mesna administration (Arm A: i.v. in equal doses 15 min before and 4 h and 8 h after ifosfamide; Arm B: three equivalent doses 15 min before (i.v.) and 4 h (i.v.) and 8 h (p.o., double dose); Arm C: i.v. in two equal doses 15 min before and 4 h after).
Trial: 43585
Drug: methyl-salazosulphapyridine (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: methyl-salazosulphapyridine (125 mg x 3 daily)
Trial: 43585
Drug: salazosulphapyridine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: salazosulphapyridine (1 g x 3 daily)
Trial: 24028354
Drug: Medication reviews
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication reviews performed by a physician
Trial: 12779351
Drug: Nephrectomy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nephrectomy followed by treatment with interferon alfa‐2b
Trial: 12779351
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with interferon alfa‐2b alone
Trial: 4027102
Drug: MST Continus
RxNorm normalized name: MST Continus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MST Continus 20 mg (oral morphine)
Trial: 29546298
Drug: 3 L
RxNorm normalized name: D3 Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 L semiskimmed milk/wk
Trial: 29546298
Drug: Usual milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual milk consumption (baseline median: 140 mL/d; IQR: 40‐240 mL/d)
Trial: 26893546
Drug: Multimatrix mesalamine
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multimatrix mesalamine 30 mg/kg/day
Trial: 26893546
Drug: Multimatrix mesalamine
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multimatrix mesalamine 60 mg/kg/day
Trial: 26893546
Drug: Multimatrix mesalamine
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multimatrix mesalamine 100 mg/kg/day
Trial: 26893546
Drug: Multimatrix mesalamine
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multimatrix mesalamine (all doses)
Trial: 20610636
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D insufficiency (serum 25(OH)D concentration < 30 ng/mL)
Trial: 18331221
Drug: 10% water
RxNorm normalized name: amino acids 8 % in dextrose 10% water 8 %-10 % INTRAVEN INTRAVENOUS SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% water solution of sucrose (CHO; 4 kcal/kg body mass)
Trial: 15980352
Drug: 873140 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 873140 50 mg to 800 mg single dose
Trial: 15980352
Drug: 873140 200
RxNorm normalized name: dimethicone 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 873140 200 mg to 800 mg repeat dose (BID for 8 days)
Trial: 15980352
Drug: Food consumption
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Food consumption with 400 mg dose
Trial: 15980352
Drug: 873140 200
RxNorm normalized name: dimethicone 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 873140 200 mg BID
Trial: 15980352
Drug: 873140 800
RxNorm normalized name: Peptimax 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 873140 800 mg BID
Trial: 3291223
Drug: Cs monotherapy
RxNorm normalized name: MyoGesic-CS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cs monotherapy (8 to 10 mg/kg/d)
Trial: 3291223
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Cs, azathioprine, and prednisolone or Cs and azathioprine)
Trial: 766879
Drug: Wistar RA
RxNorm normalized name: Rubivirus rubella virus Wistar RA 27/3 whole
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wistar RA 27/3 vaccine
Trial: 766879
Drug: Cendehill strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cendehill strain live attenuated vaccine
Trial: 23932803
Drug: Other cholesterol-lowering
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other cholesterol-lowering medications
Trial: 23932803
Drug: No cholesterol-lowering
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No cholesterol-lowering agents (Control group)
Trial: 18155058
Drug: Lidocaine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (5 mg/kg bolus dose)
Trial: 18155058
Drug: Lidocaine with
RxNorm normalized name: Lidocaine with Tegaderm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine with epinephrine (5 mcg/mL)
Trial: 20617345
Drug: Hospital-prepared supplements
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital-prepared supplements
Trial: 20617345
Drug: Commercially available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercially available supplements
Trial: 20617345
Drug: Hospital supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital supplements
Trial: 12002666
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of latanoprost 0.005% and timolol 0.5%
Trial: 8071762
Drug: Benzathine penicillin
RxNorm normalized name: Benzathine penicillin G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzathine penicillin G
Trial: 8071762
Drug: Procaine penicillin
RxNorm normalized name: procaine penicillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaine penicillin G
Trial: 2847079
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg IM daily of purified bovine brain gangliosides (Cronassial)
Trial: 2847079
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg IM daily of purified bovine brain gangliosides (Cronassial)
Trial: 24927471
Drug: Internet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet treatment (NET)
Trial: 22616078
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone for 2 weeks and intranasal budesonide for 12 weeks
Trial: 17852670
Drug: Very high
RxNorm normalized name: Very high density lipoprotein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very high molecular weight glucose polymer solution
Trial: 17852670
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight glucose polymer solution
Trial: 11788414
Drug: Diuretic (spironolactone:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretic (spironolactone: 100 mg/day, 3 days)
Trial: 10412846
Drug: Original plaque
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Original plaque index derived from buccal surfaces of all teeth
Trial: 2110425
Drug: Midazolam (0.16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.16 mg/kg) with flumazenil (0.55 mg)
Trial: 2110425
Drug: Propofol (1.50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (1.50 mg/kg)
Trial: 2110425
Drug: Midazolam (0.16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.16 mg/kg)
Trial: 383023
Drug: Naloxone IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone IV (0.01 mg/kg)
Trial: 383023
Drug: Naloxone IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone IV (0.02 mg/kg)
Trial: 3109893
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antagonist)
Trial: 21551966
Drug: Sentinel lymph
RxNorm normalized name: Sentinel Spectrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sentinel lymph node biopsy using dual-agent injection of blue dye and radioactive colloid
Trial: 17442659
Drug: Ibandronate 50
RxNorm normalized name: ibandronic acid 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 50 mg/day
Trial: 17442659
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid 4 mg every 4 weeks
Trial: 14696020
Drug: Olopatadine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olopatadine (10 mg)
Trial: 14696020
Drug: d-chlorpheniramine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-chlorpheniramine (4 mg)
Trial: 8639180
Drug: IL-10 and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-10 and IL-4 (combination)
Trial: 1600042
Drug: Cisapride 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 2.5 mg three times daily for 7 days
Trial: 1600042
Drug: Cisapride 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 2.5 mg plus Domperidone 10 mg three times daily for 7 days
Trial: 29428919
Drug: Kangaroo mother
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kangaroo mother care with Music therapy
Trial: 24658964
Drug: Imatinib 400
RxNorm normalized name: imatinib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib 400 mg/day (IM400)
Trial: 24658964
Drug: Imatinib 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib 800 mg/day (IM800)
Trial: 20075953
Drug: Novel vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel vaccine adjuvant system
Trial: 20075953
Drug: Standard HBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard HBV vaccine
Trial: 17914132
Drug: Proprietary formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proprietary formulation of Camellia sinensis (green tea) capsules, twice a day for 3 months
Trial: 17914132
Drug: Placebo capsules,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules, twice a day for 3 months
Trial: 9831059
Drug: Aceclofenac 150
RxNorm normalized name: Acéclofénac
DrugBank: Aceclofenac (DB06736)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aceclofenac 150 mg
Trial: 7924164
Drug: acute hyperinsulinaemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: acute hyperinsulinaemic hypoglycaemia (60 m-units min-1 m-2, 2.5 mmol/l)
Trial: 7924164
Drug: prolonged hyperinsulinaemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prolonged hyperinsulinaemic hypoglycaemia (60 m-units min-1 m-2, 2.5 mmol/l)
Trial: 7924164
Drug: euglycaemia (4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: euglycaemia (4.5 mmol/l)
Trial: 54631
Drug: Influenza-B vaccine
RxNorm normalized name: influenza B virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza-B vaccine
Trial: 54631
Drug: Influenza-A vaccine
RxNorm normalized name: influenza A virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza-A vaccine (A/Hong Kong)
Trial: 54631
Drug: Influenza-B H.I.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza-B H.I. antibody